Multidisciplinary consensus of best practice for pro re nata (PRN) psychotropic medications within acute mental health settings: a Delphi study.
There is a limited evidence base for the use of pro re nata (PRN) 'as required' psychotropic medication within acute mental health settings. This study aimed to explore expert opinion concerning issues and best practice for the prescribing and administration of psychotropic PRN medications within acute inpatient mental health settings. Eighteen experts participated in three Delphi rounds of a modified Delphi panel to establish consensus. A total of 271 items were initially generated from four questions. As a result of the consensus process the number of items retained reduced to 78, then 34 items and finally 13 items. Clinicians' practice could be informed by the 13 recommendations established by the Delphi panel. Further research is required to establish the clinical effectiveness of these recommendations.
Baker
J A
JA
School of Nursing, Midwifery and Social Work, The University of Manchester, Manchester, UK. john.a.baker@manchester.ac.uk
Lovell
K
K
Harris
N
N
Campbell
M
M
D000208:Acute Disease; D001291:Attitude of Health Personnel; D019985:Benchmarking / Q000458:organization & administration*; D003697:Delphi Technique; D004334:Drug Administration Schedule; D016903:Drug Monitoring; D004739:England; D019317:Evidence-Based Medicine; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy*; D009720:Nurse Clinicians / Q000458:organization & administration / Q000523:psychology; D009730:Nursing Assessment; D010348:Patient Care Team / Q000458:organization & administration*; D018579:Patient Selection; D010595:Pharmacists / Q000458:organization & administration / Q000523:psychology; D017410:Practice Guidelines as Topic; D024382:Professional Role; D011568:Psychiatric Nursing / Q000458:organization & administration; D011570:Psychiatry / Q000458:organization & administration; D011619:Psychotropic Drugs / Q000008:administration & dosage*; D011795:Surveys and Questionnaires
D011619:Psychotropic Drugs